Standard & Poor’s will monitor this transaction, and post any relevant updates on its website: www.standardandpoors.com.
Invitrogen develops, manufactures and markets research products for biotechnology and biopharmaceutical researchers in corporate, academic and governmental organizations. Headquartered in Carlsbad, CA, the company will be added to the S&P MidCap 400 GICS (Global Industry Classification Standard) Biotechnology Sub-Industry Index.
Following is a summary of the change:
| S&P MIDCAP 400 INDEX – September 20, 2004 | |||
| COMPANY | GICS ECONOMIC SECTOR | GICS SUB-INDUSTRY | |
| ADDED | Invitrogen Corp. | Health Care | Biotechnology |
| DELETED | Interstate Bakeries | Consumer Staples | Packaged Foods & Meats |
Additions to and deletions from an S&P equity index do not in any way reflect an opinion on the investment merits of the companies concerned.
Standard & Poor's, a division of The McGraw-Hill Companies (NYSE:MHP), is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research, data and valuations. With 5000 employees located in 20 countries, Standard & Poor's is an essential part of the world's financial infrastructure, and has played a leading role for more than 140 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit www.standardandpoors.com.
Founded in 1888, The McGraw-Hill Companies is a leading global information services provider meeting worldwide needs in the financial services, education and business information markets through leading brands such as Standard & Poor's, BusinessWeek and McGraw-Hill Education. The Corporation has more than 280 offices in 40 countries. Sales in 2003 were $4.8 billion. Additional information is available at www.mcgraw-hill.com.
